ALDEI Share Price Performance
€0
0.00 (0.00%)
Price €0
Share Pricen/a
Deinove SA Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
ALDEI Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Deinove SA Key Details
Last Reported Earnings
Jun 30, 2022
Next Reporting Earnings
n/a
- -0.23
- -1,521.58%
- -3,058.92%
- -127.0%
About ALDEI
- Founded
- 2006
- Employees
- 44
- CEO
- WebsiteView website
DEINOVE SA, a biotechnology company, discovers, develops, and produces compounds from microbials for the health, nutrition, and cosmetics industries worldwide. The company’s pipeline includes DNV3837, an antibiotic, which is in the Phase II clinical trial for the treatment of Clostridioides difficile infections. It also offers Dual-Acting Small Molecule Antibiotics, a class of dual activity antibiotics that develops a new class of 2-in-1 molecules whose structure results from the combination of two active antibiotic moieties. The company was founded in 2006 and is based in Grabels, France.
